About: Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic
Creator	Adrovic, Amra Aliyeva, Ayten Haslak, Fatih Kasapcopur, · Kenan Barut, · Koker, Oya Mehmet Yildiz, · Sahin, Sezgin
Source	Medline; PMC
abstract	Concerns regarding the comorbidity as a significant risk factor for Coronavirus Disease-2019 (COVID-19), gave rise to an urgent need for studies evaluating patients with chronic conditions such as autoinflammatory diseases (AIDs). We prepared a web-based survey investigating the clinical findings and contact histories among pediatric patients with AIDs. Confirmed COVID-19 cases, patients with contact history and those with symptoms which were highly suggestive of COVID-19 were called via phone or recruited to a video or face to face appointment. Data of AIDs were obtained from their medical records, retrospectively. Laboratory and screening findings were confirmed by our national health registry website. There were 404 patients (217 female) eligible for the enrollment. During pandemic, 375 (93%) were on colchicine treatment and 48 (11.8%) were receiving biologic treatment. Twenty-four out of 404 patients were admitted to hospital due to COVID-19 suspicion. Severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) was identified through rhinopharyngeal swabs in seven patients, six of whom were only on colchicine treatment. Only one patient with no finding of any severe respiratory complications was hospitalized. All of seven patients recovered completely. Among patients on biologic drugs, neither a symptom nor a positive polymerase chain reaction test for COVID 19 was detected. In conclusion, pediatric patients with AIDs, those receiving biologic treatment and/or colchicine, may not be at increased risk for neither being infected nor the severe disease course.
has issue date	2020-07-13(xsd:dateTime)
bibo:doi	10.1007/s00296-020-04645-x
bibo:pmid	32661928
has license	no-cc
sha1sum (hex)	45645f0af5987e4684f7643f369af4bdd4a32726
schema:url	https://doi.org/10.1007/s00296-020-04645-x
resource representing a document's title	Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic
has PubMed Central identifier	PMC7355083
has PubMed identifier	32661928
schema:publication	Rheumatol Int
resource representing a document's body	covid:45645f0af5987e4684f7643f369af4bdd4a32726#body_text
is schema:about of	named entity 'screening' named entity 'patients' named entity 'comorbidity' named entity 'symptom' named entity 'face' named entity 'identified' named entity 'patients' named entity 'Coronavirus' named entity 'SEVERE' named entity 'SCREENING' named entity 'WEBSITE' named entity 'CASES' named entity 'SUGGESTIVE OF' named entity 'FEMALE' named entity 'EVALUATING' named entity 'IDENTIFIED' named entity 'RESPIRATORY COMPLICATIONS' named entity 'COVID-19' named entity 'COLCHICINE TREATMENT' named entity 'prepared' named entity 'COVID-19' named entity 'Laboratory' named entity 'hospital' named entity 'symptoms' named entity 'respiratory' named entity 'COVID' named entity 'patients' named entity 'COVID-19' named entity 'During' named entity 'autoinflammatory' named entity 'AIDs' named entity 'patients' named entity 'patients' named entity 'medical records' named entity 'patients' named entity 'colchicine' named entity 'histories' named entity 'Management' named entity 'respiratory complications' named entity 'Coronavirus Disease' named entity 'COVID' named entity 'medical records' named entity 'COVID-19 pandemic' named entity 'autoinflammatory' named entity 'asymptomatic' named entity 'COVID-19' named entity 'COVID' named entity 'China' named entity 'PFAPA' named entity 'COVID' named entity 'COVID' named entity 'PCR test' named entity 'colchicine' named entity 'air pollution' named entity 'COVID' named entity 'COVID-19' named entity 'fatigue' named entity 'COVID-19' named entity 'Wuhan' named entity 'SPSS Inc.' named entity 'ground-glass opacities' named entity 'cytokine storm syndrome' named entity 'Wuhan' named entity 'risk factors' named entity 'COVID-19' named entity 'real-time PCR' named entity 'COVID 19' named entity 'risk factor' named entity 'COVID' named entity 'COVID' named entity 'canakinumab' named entity 'TRAPS' named entity 'PCR testing' named entity 'amyloidosis'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software